Back to Search
Start Over
PR1 peptide vaccine in myeloid malignancies.
- Source :
-
The Lancet. Oncology [Lancet Oncol] 2016 Dec; Vol. 17 (12), pp. e520. Date of Electronic Publication: 2016 Oct 27. - Publication Year :
- 2016
- Subjects :
- Cancer Vaccines adverse effects
Cancer Vaccines immunology
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Hematologic Neoplasms immunology
Hematologic Neoplasms pathology
Humans
Leukocyte Elastase immunology
Oligopeptides adverse effects
Oligopeptides immunology
Receptor, PAR-1 immunology
Treatment Outcome
Cancer Vaccines therapeutic use
Hematologic Neoplasms drug therapy
Oligopeptides therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1474-5488
- Volume :
- 17
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- The Lancet. Oncology
- Publication Type :
- Periodical
- Accession number :
- 28100433
- Full Text :
- https://doi.org/10.1016/S1470-2045(16)30552-6